HPV status‐independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas
暂无分享,去创建一个
C. Eng | J. Hunt | R. Seth | J. Scharpf | Walter T. Lee | Kristi L. Bennett | Xiatong Zhang | K. Bennett | E. Lamarre | Walter T. Lee | Eric Lamarre
[1] J. Kao,et al. HPV-induced oropharyngeal cancer, immune response and response to therapy. , 2010, Cancer letters.
[2] Saskia M Wilting,et al. Repression of MAL tumour suppressor activity by promoter methylation during cervical carcinogenesis , 2009, The Journal of pathology.
[3] Scott M Langevin,et al. Recurrence in oral and pharyngeal cancer is associated with quantitative MGMT promoter methylation , 2009, BMC Cancer.
[4] C. Hung,et al. Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency. , 2009, Vaccine.
[5] Alyce A. Chen,et al. Genetic variation in the vitamin C transporter, SLC23A2, modifies the risk of HPV16-associated head and neck cancer. , 2009, Carcinogenesis.
[6] N. Kisseljova,et al. Hypermethylation of genomic 3.3-kb repeats is frequent event in HPV-positive cervical cancer , 2009, BMC Medical Genomics.
[7] S. Warnakulasuriya. Global epidemiology of oral and oropharyngeal cancer. , 2009, Oral oncology.
[8] K. Baggerly,et al. Genome-Wide Hypomethylation in Head and Neck Cancer Is More Pronounced in HPV-Negative Tumors and Is Associated with Genomic Instability , 2009, PloS one.
[9] Steven S. Chang,et al. Presence of HPV DNA in convalescent salivary rinses is an adverse prognostic marker in head and neck squamous cell carcinoma. , 2008, Oral oncology.
[10] Dong M Shin,et al. Recent advances in head and neck cancer. , 2008, The New England journal of medicine.
[11] C. Plass,et al. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. , 2008, Cancer research.
[12] J. Schouten,et al. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis , 2007, British Journal of Cancer.
[13] Carole Fakhry,et al. Case-control study of human papillomavirus and oropharyngeal cancer. , 2007, The New England journal of medicine.
[14] V. Ganapathy,et al. SLC5A8 triggers tumor cell apoptosis through pyruvate-dependent inhibition of histone deacetylases. , 2006, Cancer research.
[15] K. Robertson,et al. An EBF3-mediated transcriptional program that induces cell cycle arrest and apoptosis. , 2006, Cancer research.
[16] J. Weissfeld,et al. 11q13 amplification status and human papillomavirus in relation to p16 expression defines two distinct etiologies of head and neck tumours , 2006, British Journal of Cancer.
[17] J. Simons,et al. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis. , 2006, Cancer research.
[18] A. Bosserhoff,et al. Cloning and functional characterization of a new Ski homolog, Fussel-18, specifically expressed in neuronal tissues , 2005, Laboratory Investigation.
[19] S. Gollin. Mechanisms leading to chromosomal instability. , 2005, Seminars in cancer biology.
[20] D. Groneberg,et al. SMAD-signaling in chronic obstructive pulmonary disease: transcriptional down-regulation of inhibitory SMAD 6 and 7 by cigarette smoke , 2004, Biological chemistry.
[21] P. Sharpe,et al. The role of effectors of the activin signalling pathway, activin receptors IIA and IIB, and Smad2, in patterning of tooth development. , 2001, Development.
[22] A. Wolffe,et al. Relationships between chromatin organization and DNA methylation in determining gene expression. , 1999, Seminars in cancer biology.
[23] E. Sekinger,et al. Chromatin and cancer: Causes and consequences , 2000, Journal of cellular biochemistry. Supplement.